Nanoengineered drug releasing aluminium wire implants: a model study for localized bone therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Orthopedic Drug Delivery

Background:

• Localized drug delivery in bone is crucial for treating infections, promoting healing, and managing bone diseases.
• Current methods face challenges in achieving sustained release and biocompatibility.
• Nanoengineered implants offer potential for improved therapeutic outcomes.

Purpose of the Study:

• To explore nanoengineered aluminium wire implants for localized drug delivery in bone.
• To investigate the influence of nanoporous alumina layer thickness on drug release kinetics.
• To evaluate the biocompatibility and in vivo performance of these implants.

Main Methods:

• Fabrication of aluminium wire implants with nanoporous alumina (NPA) layers via electrochemical anodization.
• In vitro drug release studies using a model drug and varying NPA layer thicknesses (pore lengths).
• Ex vivo drug release evaluation in a bone reactor and in situ monitoring.
• Biocompatibility assessment using human osteoblast cell cultures.
• Histological analysis of bone-implant interfaces post-implantation.

Main Results:

• NPA layer thickness significantly influenced drug release, enabling tunable and sustained release profiles.
• Human osteoblast cells exhibited robust growth, spreading, and adhesion on the implant surface.
• Ex vivo studies demonstrated consistent, slow drug release and distribution within bone tissue.
• Implant morphology remained stable, and bone histology confirmed the presence of viable osteocytes, indicating safety.

Conclusions:

• Needle-guided implantation of drug-loaded, nanoengineered porous wires is a viable strategy for localized bone therapy.
• These NPA wire implants are biocompatible and demonstrate controlled, sustained drug release.
• This technology holds promise for treating bone infections, enhancing healing, and potentially managing bone cancer.